Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.
2.

[Atypical neuroleptics in the treatment of aggression and hostility in schizophrenic patients].

Briken P, Nika E, Krausz M, Naber D.

Fortschr Neurol Psychiatr. 2002 Mar;70(3):139-44. Review. German.

PMID:
11880946
3.

Management of aggression, agitation, and psychosis in dementia: focus on atypical antipsychotics.

Aupperle P.

Am J Alzheimers Dis Other Demen. 2006 Mar-Apr;21(2):101-8. Review.

PMID:
16634465
5.

Atypical antipsychotic medications in the psychiatric emergency service.

Currier GW.

J Clin Psychiatry. 2000;61 Suppl 14:21-6. Review.

6.
7.

Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol.

Volavka J, Czobor P, Nolan K, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Cooper TB, Lieberman JA.

J Clin Psychopharmacol. 2004 Apr;24(2):225-8.

PMID:
15206671
8.

Quality of life and atypical antipsychotics.

Rudnick A.

J Clin Psychopharmacol. 1998 Oct;18(5):424-5. No abstract available.

PMID:
9790165
9.

Psychopharmacological treatment of aggression in schizophrenic patients.

Brieden T, Ujeyl M, Naber D.

Pharmacopsychiatry. 2002 May;35(3):83-9. Review.

PMID:
12107851
10.

A review of agitation in mental illness: treatment guidelines and current therapies.

Marder SR.

J Clin Psychiatry. 2006;67 Suppl 10:13-21. Review.

11.

Rationale and guidelines for the inpatient treatment of acute psychosis.

Feifel D.

J Clin Psychiatry. 2000;61 Suppl 14:27-32. Review.

12.

Clozapine: a comparison with other novel antipsychotics.

Fleischhacker WW.

J Clin Psychiatry. 1999;60 Suppl 12:30-4. Review.

13.

Pharmacological management of agitation in emergency settings.

Yildiz A, Sachs GS, Turgay A.

Emerg Med J. 2003 Jul;20(4):339-46. Review.

14.
15.

[Parenteral Antipsychotics in the Treatment of Agitation and Aggression].

Utzerath G, Reske D, Gouzoulis-Mayfrank E.

Fortschr Neurol Psychiatr. 2015 Dec;83(12):665-75. doi: 10.1055/s-0041-109986. Epub 2015 Dec 29. Review. German.

PMID:
26714248
16.

National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology.

Schneider LS, Tariot PN, Lyketsos CG, Dagerman KS, Davis KL, Davis S, Hsiao JK, Jeste DV, Katz IR, Olin JT, Pollock BG, Rabins PV, Rosenheck RA, Small GW, Lebowitz B, Lieberman JA.

Am J Geriatr Psychiatry. 2001 Fall;9(4):346-60.

PMID:
11739062
17.

Pharmacological management of acute and persistent aggression in forensic psychiatry settings.

Citrome L, Volavka J.

CNS Drugs. 2011 Dec 1;25(12):1009-21. doi: 10.2165/11596930-000000000-00000. Review.

PMID:
22133324
18.

Atypical antipsychotic drugs and long-term outcome in schizophrenia.

Weiden P, Aquila R, Standard J.

J Clin Psychiatry. 1996;57 Suppl 11:53-60. Review.

PMID:
8941171
19.

Clinical perspectives on atypical antipsychotics for treatment of agitation.

Caine ED.

J Clin Psychiatry. 2006;67 Suppl 10:22-31. Review.

20.

[Treatment of schizophrenia in subjects with substance use disorders: A review].

Rubio Valladolid G, Casas Brugué M.

Actas Esp Psiquiatr. 2001 Mar-Apr;29(2):124-30. Review. Spanish.

PMID:
11333531

Supplemental Content

Support Center